MedTrace Logo

Liver Regional Oxygen Saturation in Preterm Patent Ductus Arteriosus

NCT05639309 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2025-05-30

No results posted yet for this study

Summary

This study evaluates the usefulness of liver perfusion and oxygenation status using regional oxygen saturation (RSO2) values obtained via near-infrared spectroscopy in assessing the hemodynamical significance of patent ductus arteriosus in preterm infants.

Conditions

  • Patent Ductus Arteriosus
  • Circulation
  • Newborn Morbidity
  • Premature Birth

Interventions

DEVICE

near-infrared spectroscopy based cerebral/somatic oximeter system (INVOS™ system manufactured by Medtronics)

regional oxygen saturation measurement

Sponsors & Collaborators

Principal Investigators

  • Sook Kyung Yum, MD, PhD · Seoul St. Mary's Hospital, Catholic Univeristy of Korea

Eligibility

Max Age
4 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-13
Primary Completion
2025-03-31
Completion
2025-03-31
FDA Device
Yes

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05639309 on ClinicalTrials.gov